Movatterモバイル変換


[0]ホーム

URL:


USRE37454E1 - Cardiac pacemaker with hystersis behavior - Google Patents

Cardiac pacemaker with hystersis behavior
Download PDF

Info

Publication number
USRE37454E1
USRE37454E1US08/547,350US54735095AUSRE37454EUS RE37454 E1USRE37454 E1US RE37454E1US 54735095 AUS54735095 AUS 54735095AUS RE37454 EUSRE37454 EUS RE37454E
Authority
US
United States
Prior art keywords
rate
pacing
avg
interval
lrhi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US08/547,350
Inventor
Richard Sutton
Ivan Bourgeois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic IncfiledCriticalMedtronic Inc
Priority to US08/547,350priorityCriticalpatent/USRE37454E1/en
Application grantedgrantedCritical
Publication of USRE37454E1publicationCriticalpatent/USRE37454E1/en
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

A pacemaker having a hysteresis feature which permits intrinsic heart activity, controlled by the sinus node to resume optimally after pacing. The pacemaker has a programmable lower rate and upper rate, a programmable lower hysteresis rate (LRH) corresponding to a lower rate hysteresis interval (LRHI), and a programmable rate (IR) intermediate an upper pacing rate (UR) and a lower pacing rate (LR). A microprocessor measures the average rate of change MAVG in the intervals between consecutive ventricular depolarizations, and compares the last intrinsic escape interval RRN to the lower rate hysteresis interval (LRHI).If the last intrinsic escape interval RRN is longer than the lower rate hysteresis interval (LRHI), and if the value of MAVG is greater than a first preselected value SL1 but less than a second preselected value SL2, the pacemaker stimulates at the lower rate hysteresis (LRH) and thereafter gradually increases the pacing rate up to the intermediate rate (IR). A time counter maintains a continuous pacing at the intermediate rate (IR) for a predefined period of time, and the pacing rate is gradually decreased toward the lower pacing rate (LR).

Description

BACKGROUND OF THE INVENTION
The present invention relates to cardiac pacemakers, and more specifically to a pacemaker having a selectable hysteresis feature which compensates for sinus node malfunction.
It is well known that natural heart activity, including the depolarization of the sinus node provides optimum hemodynamic performance. Atrial or ventricular stimulations induced by such devices as cardiac pacemakers, generally delay or inhibit natural heart activity by preventing the depolarization of the sinus node.
The hysteresis feature was developed to address this concern, by allowing the pacemaker to follow the sensed sinus node depolarization to a certain predetermined rate below the programmed lower rate of the pacemaker. As such, the escape interval in conventional demand pacemakers equipped with hysteresis feature, is longer than the lower rate interval, for enabling the patient's intrinsic rhythm to control the heart as long as the intrinsic rate is maintained above a predetermined minimum rate. However, in selected patients, these conventional pacemakers do not generally allow the natural heart activity to resume normally after pacing.
The following patents provide a brief historical background for the development and use of the hysteresis feature as it relates to cardiac pacing technology. U.S. Pat. No. 4,856,523, entitled “RATE-RESPONSIVE PACEMAKER WITH AUTOMATIC MODE SWITCHING AND/OR VARIABLE HYSTERESIS RATE,” issued to Sholder et al, on Aug. 15, 1989, describes the inclusion of the hysteresis feature in a rate-responsive pacemaker, in an attempt to prevent competition between the pacemaker and the heart's SA node, when the anterograde conduction path is restored. The Sholder patent proposes to vary the hysteresis rate as a function of the pacemaker sensor rate, to a predetermined level upon sensing of the natural heart contraction during the escape interval, as illustrated in FIG. 3B and 4.
U.S. Pat. No. 4,363,325 entitled “MODE ADAPTIVE PACER,” issued to Roline et al, on Dec. 14, 1982, and assigned to Medtronic, Inc., discloses a multiple-mode pacer which automatically switches from an atrial synchronous mode to a ventricular inhibited mode when the intrinsic atrial rate drops below a preset hysteresis rate. The Roline patent is incorporated herein by reference.
While the above cited patents and other publications and studies relating to the hysteresis feature have attempted with varying degrees of success to allow the patient's intrinsic rhythm to control, none was completely successful in causing the natural heart activity to resume optimally after pacing.
SUMMARY OF THE INVENTION
Briefly, the above and further objects and features of the present invention are realized by providing a new and improved pacemaker having a hysteresis feature which permits intrinsic heart activity, controlled by the sinus node to resume optimally after pacing.
The pacemaker has a programmable lower rate and upper rate, a programmable lower hysteresis rate (LRH) corresponding to a lower rate hysteresis interval (LRHI), and a programmable rate (IR) intermediate an upper pacing rate (UR) and a lower pacing rate (LR). A microprocessor measures the average rate of change in the intervals between consecutive ventricular depolarizations MAVG, and compares the last intrinsic escape (RRN) interval to the lower rate hysteresis interval (LRHI).
If the last intrinsic ventricular interval(RRN) will be longer than the lower rate hysteresis interval (LRHI), and if the value of MAVGis greater than a first preselected value SL1but less than a second preselected value SL2, the pacemaker stimulates at the lower rate hysteresis (LRH) and thereafter gradually increases the pacing rate up to the intermediate rate (IR) while the pulse generator is in the demand mode. A time counter maintains a continuous pacing at the intermediate rate (IR) for a predefined period of time, and the pacing rate is gradually decreased down to the lower pacing rate (LR).
The accompanying Table I summarizes the features offered by the present invention, and correlates these features to FIGS. 2A through 6.
TABLE 1
FIG. 2AFIG. 2BFIG. 3FIG. 4FIG. 5FIG. 6
(Step)(Step)(Region)(Curve)(Curve)(Curve)
220,IKL
222 
220,VILPQ
224 
226,IIIK′L
228,
232 
226,IVLPQ
228,
230 
226,IIABAB
234,
236 
226,VBCDEFBB′CDE′R
234,
238-254
BRIEF DESCRIPTION OF THE DRAWINGS
The above and other options, features and advantages of the present invention will be more apparent from the following more particular description thereof, presented in conjunction with accompanying drawings, wherein:
FIG. 1 is a block diagram showing the primary functional blocks of the pacemaker according to the present invention;
FIGS. 2A and 2B are flow charts of a simplified software program suitable for use in the pacemaker of FIG. 1;
FIG. 3 is an illustration of two exemplary generally increasing limit functions SL1and SL2which determine the behavior of the pacemaker according to the software program of FIGS. 2A and 2B;
FIG. 4 is a response curve illustrating the variation of the pacing rate according to the present invention;
FIG. 5 is another response curve illustrating pacing rate variation according to the present invention; and
FIG. 6 is yet another response curve illustrating pacing rate variation according to the present invention.
DESCRIPTION OF THE PREFERRED EMBODIMENT
Referring now to the drawings and more particularly to FIG. 1 thereof, there is illustrated a block diagram of the components of thepacemaker100 of the present invention.Block150 illustrates a microprocessor chip, such as the CDP1802 microprocessor made by RCA. Themicroprocessor150 is connected to aROM memory151 and to aRAM memory152 via adata bus156. Anaddress bus154 interconnects theROM memory151, theRAM memory152, and acontroller circuit158. Thecontroller circuit158, in turn, controls apacer circuit161 and apacemaker output stage160 for stimulating the heart. Thepacemaker100 could be used for single chamber or dual chamber pacing.
FIGS. 2A and 2B together illustrate the flow diagram of a program200 which is stored in theROM memory151, and which is run once each cycle in thepacemaker100. Alternatively, the program200 could be stored in theRAM memory152. The program200 does not contain all the steps which are carried out by themicroprocessor150, but it includes those steps that illustrate the operation of thepacemaker100 according to the present invention. Several variables of the software-controlled operations can be reprogrammed through theRAM memory152.
Before proceeding with a more detailed explanation of the present invention, it would be helpful to review the following definitions:
“Intrinsic rhythm” or “intrinsic rate” of the heart is the rate at which the heart naturally beats on its own, without being stimulated by a pacemaker-provided stimulus.
“Hysteresis” means extension of the range of rates at which inhibition of the pacemaker pulses will occur. The base pacing interval is increased by the hysteresis interval. Thus, hysteresis provides a longer escape interval, thereby giving the heart an opportunity to beat on its own before the pacer provides stimulation pulses.
“Pacing Rate” is the rate at which the stimulation pulses are provided from the heart from the pacemaker.
Starting atstep201, the program200 is initiated, and the intrinsic ventricular depolarizations are sensed at202. While the program200 uses ventricular events for carrying out the invention, it should be understood that atrial events can alternatively be used.
The program200 measures, atstep204, the intrinsic escape interval, such as the RR interval between two successive sensed ventricular events, and calculates, atstep206, a parameter “D”, as follows:
D=RRi-RRi-1,   (1)
where RRiis the RR interval which has been recently measured atstep204; and RRi-1is the RR interval preceding RRi. It therefore follows that the parameter D is indicative of the rate of change of the RR interval.
In this respect, if D were found to have a positive value, it is an indication that the RR interval is increasing with time, and consequently the intrinsic rate of the heart is dropping. The reverse holds true where D has a negative value, indicating that the RR interval is decreasing and that the intrinsic rate is increasing. Additionally, the absolute value of D represents the rate of change of the intervals of the intrinsic ventricular depolarizations, which is also illustrated by the slope the curve AB in FIGS. 5 and 6, as it will be described later in greater detail.
If atstep208 the value of D is found to be negative, this value will not be used since it represents an increase in the intrinsic ventricular depolarization rate, and the above subroutine, includingsteps202,204,206 andstep208, is repeated until a positive value of D is found. The dashedline207 indicates that if the value of D is found to be negative, then the attending physician will have the option to either cause the software to set n=0, atstep203, or to restart atstep202. The preferred embodiment of the present invention relates principally to precipitous drops in heart rates, and consequently only positive values of D are added and stored at212 by the randomaccess memory RAM152.
While the preferred embodiment includes adding only those positive values of D, it will become apparent to those skilled in the art that consecutive D values could alternatively be added. The feature of selecting between consecutive and positive D values is a programmable feature, and is selectable by the attending physician.
In order to detect and ascertain the occurrence of precipitous heart rate drops, the software200 calculates the average rate of increase MAVGof a preselected number “N” of RR intervals. Preferably, MAVGis calculated over a predetermined period of time “T”. If during that period T, the value of MAVGis less than a first limit function SL1, then this is an indication that the intrinsic heart rate has not dropped rapidly enough to warrant the use of corrective measures, such as the activation of the hysteresis feature. If on the other hand, the value of MAVGreaches or exceeds the first limit SL1, but is less than a second limit SL2, the pacemaker is instructed to take appropriate measures, as will be described later in greater detail.
To achieve this function, the program200 stores the calculated positive values of D, atstep212, and counts the number of events “n” indicative of a positive D value. When the count reaches a preprogrammed number “N” of stored beats or reaches the time period T, the program200 calculates the sum “M” of the N stored values D, as follows:M=j=1NDj,(2)
Figure USRE037454-20011127-M00001
where j is an integer that varies between 1 and N; and where N is the number of stored beats.
The value of M is then averaged atstep217 over the number of stored beats N, as follows:MAVG=MN(3)
Figure USRE037454-20011127-M00002
In the preferred mode of the present invention the above parameters are assigned the following values:
N=6 beats.
T=15 seconds. It should, however, be understood that different values or ranges of values can alternatively be employed within the scope of the invention.
Digressing from the flow chart of FIG. 2A, and turning to FIG. 3, there is a shown lower limit function SL1and an upper limit function SL2which are identified by the numeral references10 and12, and which divide the quadrant into six regions: I, II, III, IV, V and VI. Each one of these regions will now be described in greater detail in relation to FIGS. 2A through 5. The horizontal coordinate axis represents time “t”, and the vertical coordinate axis represents RR intervals “RRI”.
As used in this specification, the LRI and LRHI parameters in the following context:
“LRI” means the Lower Rate Interval which corresponds to the lower pacing rate “LR” of the pacemaker, where LRI in milliseconds equals 60,000 divided by LR in beats per minute. LR is typically programmed to 70 beats per minute.
“LRHI” means the Lower Rate Hysteresis Interval that corresponds to the lower rate hysteresis “LRH” which is typically programmed to 50 beats per minute. LRHI in milliseconds equals 60,000 divided by LRH in beats per minute.
By comparing the average rate of change MAVGto the programmable limit functions SL1and SL2, it would be possible to identify the region which corresponds to the mode of operation of thepacemaker100. SL1and SL2are boundaries between regions defining distinctly different operation of thepacemaker100. For clarity purposes, the six regions are defined as follows:
“Region I” is the portion of the quadrant defined by the lower limit function SL1and by the RRI and time axes. Thepacemaker100 operates in Region I whenever the value of MAVGis less than SL1; and the last intrinsic ventricular escape interval RRNis shorter than the lower rate hysteresis interval LRHI. Pacing is inhibited in Region I, as illustrated by the curve KL in FIG. 4, and bystep222 of FIG.2A. The curve KL shows the heart rate decreasing at a slow rate.
“Region II” is the portion of the quadrant defined by the limit functions SL1and SL2, and by the lower rate hysteresis interval LRHI axis. Thepacemaker100 operates in Region II whenever the value of MAVGis greater than SL1, but less than SL2; and the last intrinsic ventricular escape interval RRNis shorter than LRHI. Pacing is inhibited in Region II, as illustrated by the curve AB in FIGS. 5 and 6, and by step236 of FIG.2B. The curve AB shows the heart rate decreasing at an intermediate rate.
“Region III” is the portion of the quadrant defined by the upper limit function SL2, by the LRI axis and by the lower rate hysteresis interval LRHI axis. Thepacemaker100 operates in Region III whenever the value of MAVGis greater than SL2; and the last intrinsic escape interval RRNis shorter than LRHI. Pacing is inhibited in Region III, as illustrated by the curve K′L in FIG. 4, and by thestep232 of FIG.2B. The curve K′L shows the heart rate decreasing precipitously, as opposed to curve KL, which represents a more modest heart rate drop in Region I.
“Region IV” is the portion of the quadrant above the lower rate hysteresis interval LRHI axis, and defined by the RRI axis and by the upper limit function SL2. Thepacemaker100 operates in Region IV whenever the value of MAVGis greater than SL2; and the last intrinsic escape interval RRNwill be longer than LRHI. As illustrated by the curve LPQ in FIG. 4, and by thestep230 of FIG. 2B, pacing is carried out at the lower rate LR. It should however be understood that pacing could be alternatively carried out at the lower rate hysteresis LRH.
“Region V” will be the portion of the quadrant above the lower rate hysteresis interval LRHI axis, between the two limit functions SL1and SL2. Thepacemaker100 operates in Region V whenever the value of MAVGis less than SL2but greater than SL1, and the last intrinsic escape interval RRNis longer than LRHI. As illustrated by the curves BCDEF and BB′CDE′R in FIGS. 5 and 6 respectively, and bysteps238 through254 of FIG. 2B, pacing starts at the lower rate hysteresis rate LRH and gradually increases until the pacing rate reaches an intermediate pacing rate IR. Pacing at IR is maintained for a predetermined period of time, and is thereafter gradually reduced until it reaches the lower rate LR. Pacing is maintained at the lower rate until the intrinsic rate exceeds the pacemaker lower rate, as illustrated by the curve FG in FIG.5. The pacemaker operation in Region V is triggered by an intermediate rate of decrease in the intrinsic hear rate.
“Region VI” is the portion of the quadrant defined by the lower limit function and by the lower limit function SL1. Thepacemaker100 operates in Region VI whenever the value of MAVGis less than SL1; and the last intrinsic ventricular escape interval RRNwill be longer than the lower rate hysteresis interval LRHI. As illustrated by the curve LPQ in FIG. 4, and by thestep224 of FIG. 2A, pacing is carried out at the lower rate LR. It should however be understood that pacing could be alternatively carried out at the lower rate hysteresis LRH.
Returning now to FIG. 2A, the program200 compares MAVGto SL1andstep218. If MAVGis less than SL1, then a further determination is made atstep220 whether the last ventricular intrinsic escape interval RRNis less than or equal to LRHI. If it is, thepacemaker100 operates in Region I, and pacing is inhibited, as indicated bystep222 in FIG.2A and by the response curve KL in FIG.4.
If the intrinsic escape interval (RRN) is determined atstep220, to be equal to or tend to exceed LRHI, and if there is no sensed event at a shorter interval, while the pacemaker is still in the demand mode, thepacemaker100 will operate in Region IV, and stimulation is carried out at the lower pacing rate LR, as illustrated by the curve LPQ in FIG.4. The curves in FIGS. 4,5 and6 which are drawn in dashed lines indicate that pacing is inhibited, while the curves drawn in solid lines indicate that pacing is occurring.
Returning now to step218 in the flow chart of FIG. 2A, if the program200 determines that MAVGis greater than or equal to SL1then a further determination is made atstep226 whether MAVGis less than or equal to SL2. If MAVGis found to be greater than SL2then thepacemaker100 will operate in either Region III or Region IV. A further decision is made atstep228 whether the last intrinsic escape interval RRNis less than or equal to the lower rate hysteresis interval (LRHI).
If the program200 determines that RRNis less than or equal to LRHI then thepacemaker100 will operate in Region III, and as indicated bystep232 of FIG. 2B, and by the curve K′L in FIG. 4, pacing will be inhibited. If on the other hand, it is determined atstep228, that RRNis greater than LRHI, then thepacemaker100 will operate in Region IV and as indicated bystep230 of FIG. 2B, and by the curve LPQ in FIG. 4, pacing is carried out at the lower pacing rate (LR).
Thepacemaker100 identifies and reacts to intermediate drops in the intrinsic heart rate, whenever MAVGis found to be intermediate the limit functions SL1and SL2, as follows:
SL1≦MAVG≦SL2  (4)
In the above condition, the pacemaker is caused to pace at a gradually increasing pacing rate until it reaches a predetermined intermediate pacing rate (IR) which is lower than, or in certain circumstances, equal to, the upper pacing rate (UR). Demand pacing is maintained at the intermediate pacing rate (IR) for a predetermined period of time, and is thereafter reduced gradually.
With reference to FIG. 2B, the program200 determines atstep234 whether the last intrinsic escape interval RRNis less than or equal to LRHI. If it is, then thepacemaker100 will operate in Region II, and as indicated by step236, and by the curve AB in FIGS. 5 and 6, pacing is inhibited.
If however, it is determined atstep234 that RRNwill tend to be longer than LRHI, then the condition set forth in equation (6) above is satisfied, and thepacemaker100 will operate in Region V, and will respond by pacing at the lower rate hysteresis (LRH) for a predetermined period of time or a preset number of beats, as illustrated by the dashed line BB′ in FIG. 6, and bystep238 in FIG.2B.
It should however be understood that thepacemaker100 could alternatively bypassstep238 and start pacing along curve BC (FIG.5), with one paced beat at the lower rate hysteresis (LRH). In this respect, pacing is started at point B (FIG. 5) and the pacing rate is incrementally increased until it reaches the intermediate rate (IR). The intermediate rate IR is programmable, and could be changed by the attending physician. The incremental increase in the pacing rate is illustrated by the curves BC in FIGS. 5 and 6. During this period, thepacemaker100 is in the inhibited mode for single chamber pacemakers, or in the DDD or fully automated mode for dual chamber pacemakers.
The incremental increase of the pacing rate is achieved bysteps240 through244, whereby the value of the pacing rate is incrementally increased by a center increment value X (step240), and a determination is made atstep242 whether the pacing rate is less than or equal to IR. Once IR is reached, then, as indicated bystep244, a time counter is set to maintain the continuous pacing at that intermediate rate (IR) for a preselected programmable period of time, such as for five minutes. This continuous pacing at the intermediate rate is illustrated by curve CD in FIGS. 5 and 6. If during the execution of thesubroutine244 through248, an intrinsic rhythm is sensed at245, then the intrinsic rate prevails, and pacing is inhibited.
Once the counter time lapses, then, as illustrated by the curves DE and DE′ in FIG. 5 and 6 respectively, the pacing rate is gradually decreased from the intermediate pacing rate (IR), toward the lower pacing rate (LR). This decrement is achieved by the subroutine250-252, where the pacing rate is decreased by a counter decrement value Y until the pacing rate reaches the lower rate LR.
If decremental pacing is maintained until it reaches the lower rate LR, thepacemaker100 starts pacing at that lower rate, as illustrated by the curve EF in FIG. 5, and the routine200 is repeated. If an intrinsic rhythm is sensed at any time during the decremental change (curve DE′) in the pacing rate, then the intrinsic rate prevails, and pacing is inhibited, as illustrated by the curve E′RS in FIG.6. The subroutine200 is thereafter repeated.
It is therefore clear that the new approach described in the present invention teaches away from the conventional hysteresis response feature. In the present invention, whenever an intermediate drop in the heart rate occurs and the hysteresis feature is activated, the natural heart rate resumes and is tracked until it reaches the hysteresis rate. Thereafter, the pacing rate is increased until the intermediate rate (IR) is reached. Pacing at that intermediate rate is maintained for a predetermined period of time, and thereafter allowed to gradually decay toward the lower rate.
It should become apparent to those skilled in the art after reviewing the present description, that the present invention can be made an integral part of single chamber and dual chamber pacemakers which operate in one or more of the programmed modes: SSI, SSIR, DDD, DDDR, DVI, DVIR, DDI and/or DDIR. The present hysteresis feature can be applied to the atrial and/or ventricular channels of a dual chamber pacemaker.
While the following ranges reflect exemplary values of IR, LR, UR, LRH, SL1and SL2, it should be understood to those skilled in the art that other values and ranges can also be employed and/or programmed.
100 bpm≦UR≦150 bpm.
80 bpm≦IR≦100 bpm.
60 bpm≦LR≦80 bpm.
40 bpm≦LRH≦60 bpm.
2%≦SL1≦10%.
5%≦SL2≦20%.
4 beats≦N≦16 beats.
While particular embodiments of the present invention have been disclosed, it is to be understood that various different modifications are possible and are contemplated within the scope and spirit of the specification, drawings, abstract, and appended claims.

Claims (31)

What is claimed is:
1. In a pacemaker having a programmable lower rate and upper rate, a programmable lower rate hysteresis (LRH) corresponding to a lower rate hysteresis interval (LRHI), and a programmable intermediate pacing rate (IR) the improvement comprising:
A. means for measuring rate of change MAVGof successive cardiac intrinsic escape intervals;
B. means for comparing MAVGto a first predefined limit SL1;
C. means for comparing the last intrinsic escape interval to the lower rate hysteresis interval (LRHI); and
D. means for stimulating a heart at the lower rate hysteresis (LRH) and for gradually incrementing a pacing rate until the pacing ratio reaches the intermediate pacing rate (IR) if the last intrinsic escape interval is longer than the lower rate hysteresis interval (LRHI) and if said MAVGis greater than SL1.
2. The pacemaker according to claim1 further comprising:
A. time counter means for maintaining continuous pacing at the intermediate rate (IR) for a predefined period of time; and
B. means for allowing gradual decay of the pacing rate after said selected period of time has lapsed.
3. The pacemaker according to claim2, wherein said selected programmable time is set equal to five minutes.
4. The pacemaker according to claim1, wherein said means for measuring the rate of change MAVGcomprising:
A. means for measuring intervals between two successive ventricular depolarizations (RR intervals); and
B. means for averaging the rate of change MAVGof said successive RR intervals.
5. The pacemaker according to claim4, wherein said means for averaging the rate of change of said RR intervals comprises:
A. means for calculating a difference D between two successive RR intervals;
B. means for comparing said difference D to a predetermined reference value;
C. means for storing those values of D which are greater than said reference value;
D. means for calculating a sum M of N stored values of D, wherein N is a predetermined positive integer; and
E. means for setting MAVGequal to M/N.
6. The pacemaker according to claim5, wherein said means for averaging MAVGcomprising means for averaging the values of D greater than said reference value over a predefined period of time.
7. The pacemaker according to claim6, wherein said reference value is zero, and wherein only positive values of D are stored and added.
8. The pacemaker according to claim5, wherein N is set equal to six beats.
9. The pacemaker according to claim4, further including means for comparing MAVGto a second predetermined limit SL2wherein SL2has a value greater than that of SL1.
10. The pacemaker according to claim9, wherein said means for stimulating gradually increments the pacing rate until the pacing rate reaches the intermediate pacing rate (IR), if the last intrinsic escape interval RRNis longer than LRHI, and if MAVGis greater than or equal to SL1but less than or equal to SL2.
11. The pacemaker according to claim9, further comprising means for inhibiting stimulation if MAVGis greater than SL2, and if the RRNinterval is less than or equal to LRHI.
12. The pacemaker according to claim11, further comprising means for stimulating at the lower rate if MAVGis greater than SL2, and if the RRN interval will be longer than LRHI.
13. The pacemaker according to claim11, further comprising:
A. means for inhibiting stimulation if MAVGis greater than SL2, and if the RRNinterval is less than or equal to LRH; and
B. means for stimulating at the lower rate if MAVGis greater than SL2, and if the RRNinterval will be longer than LRHI.
14. The pacemaker according to claim4, further including means for inhibiting stimulation if MAVGis less than SL1, and if the last intrinsic escape interval RRNis less than or equal to LRHI.
15. The pacemaker according to claim14, further comprising means for stimulating at the lower rate if MAVGis less than SL1, and if the RRNinterval will be greater than LRHI.
16. A method for pacing with a pacemaker having a programmable lower rate and upper rate, a programmable lower hysteresis rate (LRH) corresponding to a lower rate hysteresis interval (LRHI), and a programmable intermediate pacing rate (IR), the pacing method comprising the steps of:
A. measuring a rate of change of MAVGof successive intrinsic escape intervals;
B. comparing MAVGto a first predetermined limit SL1;
C. comparing a last intrinsic escape interval RRNto the lower rate hysteresis interval (LRHI); and
D. stimulating at the lower rate hysteresis (LRH) and gradually incrementing a pacing rate until it reaches the intermediate pacing rate (IR) if the RRNinterval will be longer than the lower rate hysteresis interval (LRHI) and if said MAVGis greater than SL1.
17. The pacing method according to claim16 further comprising the steps of:
A. maintaining continuous pacing at the intermediate rate (IR) for a predefined period of time; and
B. allowing gradual decay of the pacing rate after said selected period of time has lapsed.
18. The pacing method according to claim17, wherein, said step of measuring the rate of change MAVGcomprises:
A. measuring intervals between two successive ventricular depolarizations (RR intervals); and
B. averaging the rate of change MAVGof said successive RR intervals;
19. The pacing method according to claim18, wherein said step of averaging the rate of change of said RR intervals comprises:
A. calculating a difference D between two successive RR intervals;
B. comparing the difference D to a predetermined reference value;
C. storing those values of D which are greater than said reference value;
D. calculating a sum M of N stored values of D, wherein N is a predetermined positive integer; and
E. setting MAVGequal to M/N.
20. The pacing method according to claim19, further comprising the step comparing MAVGto a second predetermined limit SL2, wherein SL2has a value greater than that of SL1.
21. The pacing method according to claim20, wherein said step of stimulating comprises gradually incrementing the pacing rate until it reaches the intermediate pacing rate (IR), if the RRN interval will be longer than LRHI, and if MAVGis greater than or equal to SL1but less than or equal to SL2.
22. The pacing method according to claim18, further comprises:
A. the step of inhibiting stimulation if MAVGis less than SL1, and if the last sensed RR interval is less than or equal to LRHI;
B. the step of stimulating at the lower rate if MAVGis less than SL1, and if the RRNinterval will be longer than LRHI;
C. the step of inhibiting stimulation if MAVGis greater than SL2, and if the RRNinterval is less than or equal to LRHI; and
D. the step of stimulating at the lower rate if MAVGis greater than SL2, and if the RRNinterval will be longer than LRHI.
23. A cardiac pacemaker comprising:
means for sensing depolarizations,
means for controlling the timing and delivery of pacing pulses to a heart, means for measuring the rate of depolarization from said sensed depolarizations and means for comparing the current rate to a recent past average rate and from said determining the rate of decrease, and means responsive to said means for determining rate decrease for generating control signals to said control means for pacing at predetermined rates above a lower pacing rate if said rate of decrease exceeds predetermined amounts.
24. A method of pacing the heat including the steps:
1)sensing electrical depolarizations within a heart chamber,
2)making a determination based on sensed depolarizations in said chamber of the intrinsic heart rate,
3)comparing the current intrinsic heart rate with previously sensed intrinsic heart rate to determine whether a rapid drop in heart rate of a predetermined size has occurred,
4)on the discovery of a rapid drop in heart rate of said predetermined size, pacing at predetermined rates higher than a lower pacing rate.
25. A method according to claim22 further comprising after step4:
decreasing the pacing rate gradually until either an intrinsic rate is established above the lower rate or the lower rate is reached whereupon pacing continues at the lower rate.
26. The method as set forth in claim24 wherein if the activity sensor indicates a sensor rate that is higher than the lower rate, pacing at the sensor rate.
27. A cardiac pacemaker, as set forth in claim23 and further comprising means for decreasing the pacing rate gradually until either an intrinsic rate is established above the lower rate or the lower rate is reached whereupon pacing continues at the lower rate.
28. A cardiac pacemaker as set forth in claim27 further comprising means for pacing at an activity sensor rate if said activity sensor rate is higher than the lower.
29. A heart stimulator comprising:
pulse generator means for generating and emitting stimulation pulses to a heart at a rate;
detector means for sensing events in said heart, including spontaneous heartbeats; and
control means, connected to said pulse generator means and to said detector means, for controlling the emission of stimulation pulses by said pulse generator means for causing the emission of a stimulation pulse if a spontaneous heartbeat rate as sensed by said detector means drops below a defined lower rate within a predetermined period and for causing said pulse generator means, when said spontaneous heartbeat rate falls below said defined lower rate within said period, to emit said stimulation pulses at rates faster than said defined lower rate.
30. A heart stimulator as set forth in claim29 wherein after emitting said stimulation pulses at a rate faster than said lower rate, said control means subsequently slows the rate of emission of said stimulation pulses down to said defined lower rate.
31. A heart stimulator as in claim29 or30 wherein if a sensor rate is higher than said defined lower rate, said, said means for controlling the timing and delivery of pacing pulses paces at a rate indicated by said sensor rate.
US08/547,3501992-02-271995-10-24Cardiac pacemaker with hystersis behaviorExpired - LifetimeUSRE37454E1 (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
US08/547,350USRE37454E1 (en)1992-02-271995-10-24Cardiac pacemaker with hystersis behavior

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US07/842,818US5284491A (en)1992-02-271992-02-27Cardiac pacemaker with hysteresis behavior
US08/547,350USRE37454E1 (en)1992-02-271995-10-24Cardiac pacemaker with hystersis behavior

Related Parent Applications (1)

Application NumberTitlePriority DateFiling Date
US07/842,818ReissueUS5284491A (en)1992-02-271992-02-27Cardiac pacemaker with hysteresis behavior

Publications (1)

Publication NumberPublication Date
USRE37454E1true USRE37454E1 (en)2001-11-27

Family

ID=25288311

Family Applications (2)

Application NumberTitlePriority DateFiling Date
US07/842,818CeasedUS5284491A (en)1992-02-271992-02-27Cardiac pacemaker with hysteresis behavior
US08/547,350Expired - LifetimeUSRE37454E1 (en)1992-02-271995-10-24Cardiac pacemaker with hystersis behavior

Family Applications Before (1)

Application NumberTitlePriority DateFiling Date
US07/842,818CeasedUS5284491A (en)1992-02-271992-02-27Cardiac pacemaker with hysteresis behavior

Country Status (3)

CountryLink
US (2)US5284491A (en)
AU (1)AU3433193A (en)
WO (1)WO1993016756A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20060129196A1 (en)*2004-12-132006-06-15Yanting DongCapture verification with intrinsic response discrimination
US20070016261A1 (en)*2005-07-122007-01-18Yanting DongMulti channel approach to capture verification
US20090069858A1 (en)*2005-04-282009-03-12Yanting DongCapture Detection for Multi-Chamber Pacing
US8521284B2 (en)2003-12-122013-08-27Cardiac Pacemakers, Inc.Cardiac response classification using multisite sensing and pacing
US8831726B2 (en)2003-12-112014-09-09Cardiac Pacemakers, Inc.Cardiac response classification using multiple classification windows

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5522859A (en)*1993-09-291996-06-04Medtronic, Inc.Sinus preference method and apparatus for cardiac pacemakers
US5540728A (en)*1994-05-201996-07-30Medtronic, Inc.Pacemaker with vasovagal snycope detection
CA2187937C (en)1994-04-292001-03-13H. Toby MarkowitzPacemaker with vasovagal syncope detection
US5501701A (en)*1994-04-291996-03-26Medtronic, Inc.Pacemaker with vasovagal syncope detection and therapy
US5676686A (en)*1994-05-201997-10-14Medtronic, Inc.Pacemaker with vasovagal syncope detection
FR2734730B1 (en)*1995-05-311997-08-22Ela Medical Sa ACTIVE IMPLANTABLE MEDICAL DEVICE, IN PARTICULAR A CARDIAC STIMULATOR OR DEFRIBRILLATOR
US5725561A (en)*1995-06-091998-03-10Medtronic, Inc.Method and apparatus for variable rate cardiac stimulation
US5814083A (en)*1995-09-291998-09-29Medtronic, IncPacemaker tachy determination based blocked on 2:1 sensing
US5759196A (en)*1995-09-291998-06-02Medtronic, Inc.Modification of pacemaker tachy response based on FFRW sensing
US8825152B2 (en)*1996-01-082014-09-02Impulse Dynamics, N.V.Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US9289618B1 (en)1996-01-082016-03-22Impulse Dynamics NvElectrical muscle controller
US7167748B2 (en)*1996-01-082007-01-23Impulse Dynamics NvElectrical muscle controller
EP0910429B1 (en)*1996-01-082005-03-16Impulse Dynamics N.V.Heart activity control apparatus using synchronized non-excitatory pre-stimulation
US8321013B2 (en)1996-01-082012-11-27Impulse Dynamics, N.V.Electrical muscle controller and pacing with hemodynamic enhancement
IL125424A0 (en)1998-07-201999-03-12New Technologies Sa Ysy LtdPacing with hemodynamic enhancement
US6415178B1 (en)*1996-09-162002-07-02Impulse Dynamics N.V.Fencing of cardiac muscles
US9713723B2 (en)1996-01-112017-07-25Impulse Dynamics NvSignal delivery through the right ventricular septum
US5713929A (en)*1996-05-031998-02-03Medtronic, Inc.Arrhythmia and fibrillation prevention pacemaker using ratchet up and decay modes of operation
DE19623046A1 (en)*1996-05-281997-12-04Biotronik Mess & Therapieg Pacemaker with hysteresis function
US5706829A (en)*1996-06-061998-01-13Creighton UniversityMethod for treating neurocardiogenic syncope
US7908003B1 (en)1996-08-192011-03-15Mr3 Medical LlcSystem and method for treating ischemia by improving cardiac efficiency
US7840264B1 (en)1996-08-192010-11-23Mr3 Medical, LlcSystem and method for breaking reentry circuits by cooling cardiac tissue
SE9603635D0 (en)*1996-10-041996-10-04Pacesetter Ab Implantable stimulator
US5782886A (en)*1997-02-281998-07-21Vitatron Medical, B.V.Pacemaker with improved hysteresis
FR2763247B1 (en)*1997-05-162000-02-18Ela Medical Sa ACTIVE IMPLANTABLE MEDICAL DEVICE, IN PARTICULAR A CARDIAC STIMULATOR, DEFIBRILLATOR AND / OR CARDIOVERTER FOR REDUCING ARRHYTHMIA EPISODES, ESPECIALLY ATRIAL ARRHYTHMIA
US5991659A (en)*1998-09-301999-11-23Vitatron Medical, B.V.Pacing system with full range sudden rate drop detection and responsive pacing intervention
US6725093B1 (en)*1998-11-062004-04-20Impulse Dynamics N.V.Regulation of excitable tissue control of the heart based on physiological input
AU1072200A (en)*1998-11-062000-05-29Impulse Dynamics N.V.Sensor-based regulation of excitable tissue control of the heart
US6587721B1 (en)1998-11-062003-07-01Impulse Dynamics N.V.Trigger-based regulation of excitable tissue control of the heart
US6675043B1 (en)1998-11-062004-01-06Impulse Dynamics N.V.Sensor-based regulation of excitable tissue control of the heart
AU759719B2 (en)*1999-02-042003-04-17Pluristem Ltd.Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
US6049735A (en)*1999-03-012000-04-11Cardiac Pacemakers Inc.Cardiac rhythm management device with detection and therapy for sudden syncopal events
WO2006073671A1 (en)2004-12-092006-07-13Impulse Dynamics NvProtein activity modification
US9101765B2 (en)1999-03-052015-08-11Metacure LimitedNon-immediate effects of therapy
US8019421B2 (en)*1999-03-052011-09-13Metacure LimitedBlood glucose level control
US8346363B2 (en)*1999-03-052013-01-01Metacure LimitedBlood glucose level control
US8700161B2 (en)*1999-03-052014-04-15Metacure LimitedBlood glucose level control
US8666495B2 (en)*1999-03-052014-03-04Metacure LimitedGastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US20040249421A1 (en)*2000-09-132004-12-09Impulse Dynamics NvBlood glucose level control
US7203535B1 (en)1999-04-012007-04-10Cardiac Pacemakers, Inc.System and method for classifying tachycardia arrhythmias having 1:1 atrial-to-ventricular rhythms
US7142918B2 (en)*2000-12-262006-11-28Cardiac Pacemakers, Inc.Apparatus and method for pacing mode switching during atrial tachyarrhythmias
US6501988B2 (en)2000-12-262002-12-31Cardiac Pacemakers Inc.Apparatus and method for ventricular rate regularization with biventricular sensing
US6430438B1 (en)1999-05-212002-08-06Cardiac Pacemakers, Inc.Cardiac rhythm management system with atrial shock timing optimization
US7062325B1 (en)1999-05-212006-06-13Cardiac Pacemakers IncMethod and apparatus for treating irregular ventricular contractions such as during atrial arrhythmia
US8064997B2 (en)*1999-05-212011-11-22Cardiac Pacemakers, Inc.Method and apparatus for treating irregular ventricular contractions such as during atrial arrhythmia
US7181278B2 (en)*1999-05-212007-02-20Cardiac Pacemakers, Inc.Apparatus and method for ventricular rate regularization
US6351669B1 (en)1999-05-212002-02-26Cardiac Pacemakers, Inc.Cardiac rhythm management system promoting atrial pacing
US6285907B1 (en)1999-05-212001-09-04Cardiac Pacemakers, Inc.System providing ventricular pacing and biventricular coordination
US7212860B2 (en)*1999-05-212007-05-01Cardiac Pacemakers, Inc.Apparatus and method for pacing mode switching during atrial tachyarrhythmias
AU1049901A (en)1999-10-252001-05-08Impulse Dynamics N.V.Cardiac contractility modulation device having anti-arrhythmic capabilities and a method of operating thereof
US6993385B1 (en)*1999-10-252006-01-31Impulse Dynamics N.V.Cardiac contractility modulation device having anti-arrhythmic capabilities and a method of operating thereof
US7027863B1 (en)1999-10-252006-04-11Impulse Dynamics N.V.Device for cardiac therapy
US6501987B1 (en)*2000-05-262002-12-31Cardiac Pacemakers, Inc.Rate smoothing control
US7039461B1 (en)*2000-05-132006-05-02Cardiac Pacemakers, Inc.Cardiac pacing system for prevention of ventricular fibrillation and ventricular tachycardia episode
US7239914B2 (en)*2000-05-132007-07-03Cardiac Pacemakers, Inc.Rate smoothing control
US6625492B2 (en)2000-05-152003-09-23Pacesetter, Inc.Implantable cardiac stimulation device with detection and therapy for patients with vasovagal syncope
US6647295B2 (en)2000-05-152003-11-11Pacesetter, Inc.Implantable cardiac stimulation device with detection and therapy for patients with vasovagal syncope
US8512220B2 (en)*2000-05-262013-08-20Cardiac Pacemakers, Inc.Rate smoothing control
US6522922B1 (en)2000-07-132003-02-18Cardiac Pacemakers, Inc.Method and apparatus for breaking pacemaker mediated bradycardia
US6424865B1 (en)2000-07-132002-07-23Cardiac Pacemakers, Inc.Ventricular conduction delay trending system and method
US6829504B1 (en)*2000-09-142004-12-07Cardiac Pacemakers, Inc.System and method for preventing recurrence of atrial tachyarrhythmia
US6512951B1 (en)2000-09-142003-01-28Cardiac Pacemakers, Inc.Delivery of atrial defibrillation shock based on estimated QT interval
US20020099414A1 (en)2000-12-042002-07-25Xander EversMethod and system for preventing the recurrence of atrial fibrillation by an implantable medical device
US6957100B2 (en)*2000-12-262005-10-18Cardiac Pacemakers, Inc.Method and system for display of cardiac event intervals in a resynchronization pacemaker
US20020087198A1 (en)*2000-12-292002-07-04Kramer Andrew P.Apparatus and method for ventricular rate regularization
US6889078B2 (en)2001-04-262005-05-03Medtronic, Inc.Hysteresis activation of accelerated pacing
US6895275B2 (en)2002-01-222005-05-17Medtronic, Inc.Methods and apparatus for detection and treatment of syncope
EP2075014B9 (en)2002-05-242012-02-01Angiotech International AgCompositions and methods for coating medical implants
US7400928B2 (en)2002-10-112008-07-15Cardiac Pacemakers, Inc.Methods and devices for detection of context when addressing a medical condition of a patient
DE602004027705D1 (en)2003-02-102010-07-29N trig ltd TOUCH DETECTION FOR A DIGITIZER
JP2006519663A (en)*2003-03-102006-08-31インパルス ダイナミックス エヌヴイ Apparatus and method for delivering electrical signals for regulating gene expression in heart tissue
US11439815B2 (en)2003-03-102022-09-13Impulse Dynamics NvProtein activity modification
US7027865B2 (en)*2003-04-162006-04-11Medtronic, Inc.Pacemaker with vasovagal syncope detection and therapy
US8792985B2 (en)*2003-07-212014-07-29Metacure LimitedGastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US7076290B2 (en)*2003-10-102006-07-11Medtronic, Inc.Method and apparatus for detecting and discriminating arrhythmias
US7194307B2 (en)*2003-12-222007-03-20Cardiac Pacemakers, Inc.Pacing method and device for preserving native conduction system
US11779768B2 (en)2004-03-102023-10-10Impulse Dynamics NvProtein activity modification
US8548583B2 (en)*2004-03-102013-10-01Impulse Dynamics NvProtein activity modification
US8352031B2 (en)*2004-03-102013-01-08Impulse Dynamics NvProtein activity modification
US7676262B1 (en)*2004-04-202010-03-09Pacesetter, Inc.Methods and devices for determining exercise compliance diagnostics
US7031766B1 (en)2004-04-202006-04-18Pacesetter, Inc.Methods and devices for determining exercise diagnostic parameters
DE202004009224U1 (en)*2004-06-142004-08-12Isra Vision Systems Ag Sensor for measuring the surface of an object
US9821158B2 (en)2005-02-172017-11-21Metacure LimitedNon-immediate effects of therapy
WO2006097934A2 (en)*2005-03-182006-09-21Metacure LimitedPancreas lead
US7907997B2 (en)*2005-05-112011-03-15Cardiac Pacemakers, Inc.Enhancements to the detection of pulmonary edema when using transthoracic impedance
AU2006259415B2 (en)*2005-06-152012-08-30Massachusetts Institute Of TechnologyAmine-containing lipids and uses thereof
US20070096897A1 (en)*2005-10-312007-05-03Welch Allyn, Inc.Attachment/location monitoring of a signal generating entity
US20070129641A1 (en)*2005-12-012007-06-07Sweeney Robert JPosture estimation at transitions between states
US7826897B2 (en)*2005-12-222010-11-02Cardiac Pacemakers, Inc.Cardiac pacemaker with pacing rate monitoring
US8326431B2 (en)*2006-04-282012-12-04Medtronic, Inc.Implantable medical device for the concurrent treatment of a plurality of neurological disorders and method therefore
US8504153B2 (en)2007-04-042013-08-06Pacesetter, Inc.System and method for estimating cardiac pressure based on cardiac electrical conduction delays using an implantable medical device
US8208999B2 (en)2007-04-042012-06-26Pacesetter, Inc.System and method for estimating electrical conduction delays from immittance values measured using an implantable medical device
US20090149904A1 (en)2007-12-112009-06-11Cardiac Pacemakers, Inc.Lv unipolar sensing or pacing vector
JP5438687B2 (en)2007-12-132014-03-12カーディアック ペースメイカーズ, インコーポレイテッド A system that provides unipolar detection vectors
US9320448B2 (en)2008-04-182016-04-26Pacesetter, Inc.Systems and methods for improved atrial fibrillation (AF) monitoring
CN104910025B (en)2008-11-072019-07-16麻省理工学院Alkamine lipid and its purposes
US8929983B2 (en)*2008-11-102015-01-06Cardiac Pacemakers, Inc.Reverse hysteresis and mode switching for intermittent pacing therapy
HUE038039T2 (en)2009-12-012018-09-28Translate Bio IncDelivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
US8934975B2 (en)2010-02-012015-01-13Metacure LimitedGastrointestinal electrical therapy
EP2609135A4 (en)2010-08-262015-05-20Massachusetts Inst Technology POLY (BETA-AMINO ALCOHOLS), THEIR PREPARATION AND USES THEREOF
US9436801B2 (en)2011-03-182016-09-06St. Jude Medical AbHemodynamic status assessment
EP2691443B1 (en)2011-03-282021-02-17Massachusetts Institute of TechnologyConjugated lipomers and uses thereof
PL2717893T3 (en)2011-06-082019-12-31Translate Bio, Inc. Lipid nanoparticle compositions and methods for mRNA delivery
US8478407B2 (en)*2011-07-282013-07-02Medtronic, Inc.Methods for promoting intrinsic activation in single chamber implantable cardiac pacing systems
WO2013185067A1 (en)2012-06-082013-12-12Shire Human Genetic Therapies, Inc.Nuclease resistant polynucleotides and uses thereof
AU2014236396A1 (en)2013-03-142015-08-13Shire Human Genetic Therapies, Inc.Methods for purification of messenger RNA
IL290953B2 (en)2013-03-142024-01-01Ethris GmbhCftr mrna compositions and related methods and uses
US9315472B2 (en)2013-05-012016-04-19Massachusetts Institute Of Technology1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
CN106413811A (en)2013-10-222017-02-15夏尔人类遗传性治疗公司Mrna therapy for argininosuccinate synthetase deficiency
EA201992208A1 (en)2013-10-222020-07-31Транслейт Био, Инк. TREATMENT OF PHENYLKETONURIA USING mRNA
KR102096796B1 (en)2013-10-222020-05-27샤이어 휴먼 지네틱 테라피즈 인크.Lipid formulations for delivery of messenger rna
SG11201608725YA (en)2014-04-252016-11-29Shire Human Genetic TherapiesMethods for purification of messenger rna
CA3211902A1 (en)2014-05-302015-12-03Translate Bio, Inc.Biodegradable lipids for delivery of nucleic acids
PE20171238A1 (en)2014-06-242017-08-24Shire Human Genetic Therapies STEREOCHEMICALLY ENRICHED COMPOSITIONS FOR NUCLEIC ACIDS ADMINISTRATION
US9840479B2 (en)2014-07-022017-12-12Massachusetts Institute Of TechnologyPolyamine-fatty acid derived lipidoids and uses thereof
WO2018157154A2 (en)2017-02-272018-08-30Translate Bio, Inc.Novel codon-optimized cftr mrna
US10864378B2 (en)2017-03-092020-12-15Cardiac Pacemakers, Inc.Pacemaker with diagnostic intrinsic beat search
US11173190B2 (en)2017-05-162021-11-16Translate Bio, Inc.Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR
EP3841208A1 (en)2018-08-242021-06-30Translate Bio, Inc.Methods for purification of messenger rna
WO2020106946A1 (en)2018-11-212020-05-28Translate Bio, Inc.TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF NEBULIZED mRNA ENCODING CFTR

Citations (7)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3661157A (en)*1969-04-161972-05-09Nat Res DevInhibited demand pacer with a two-rate pulse generator
US3857399A (en)*1970-03-241974-12-31F ZacoutoHeart pacer
US3921642A (en)*1974-07-011975-11-25Thomas A PrestonAutomatic rate adjustment pacer with natural rate searching means and method of operation
US4169480A (en)*1977-08-191979-10-02Biotronik Mess- Und Therapiegerate Gmbh & Co.Demand pacer with programmable rate hysteresis
US4363325A (en)*1981-01-191982-12-14Medtronic, Inc.Mode adaptive pacer
US4856523A (en)*1987-10-081989-08-15Siemens-Pacesetter, Inc.Rate-responsive pacemaker with automatic mode switching and/or variable hysteresis rate
US4972834A (en)*1988-09-301990-11-27Vitatron Medical B.V.Pacemaker with improved dynamic rate responsiveness

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4313442A (en)*1980-07-211982-02-02Cardiac Pacemakers, Inc.Atrial rate sensitive cardiac pacer apparatus
DE3885876T3 (en)*1988-02-012004-07-15St. Jude Medical Ab Pacemaker with a hysteresis function.

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3661157A (en)*1969-04-161972-05-09Nat Res DevInhibited demand pacer with a two-rate pulse generator
US3857399A (en)*1970-03-241974-12-31F ZacoutoHeart pacer
US3921642A (en)*1974-07-011975-11-25Thomas A PrestonAutomatic rate adjustment pacer with natural rate searching means and method of operation
US4169480A (en)*1977-08-191979-10-02Biotronik Mess- Und Therapiegerate Gmbh & Co.Demand pacer with programmable rate hysteresis
US4363325A (en)*1981-01-191982-12-14Medtronic, Inc.Mode adaptive pacer
US4856523A (en)*1987-10-081989-08-15Siemens-Pacesetter, Inc.Rate-responsive pacemaker with automatic mode switching and/or variable hysteresis rate
US4972834A (en)*1988-09-301990-11-27Vitatron Medical B.V.Pacemaker with improved dynamic rate responsiveness

Cited By (12)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US8831726B2 (en)2003-12-112014-09-09Cardiac Pacemakers, Inc.Cardiac response classification using multiple classification windows
US8521284B2 (en)2003-12-122013-08-27Cardiac Pacemakers, Inc.Cardiac response classification using multisite sensing and pacing
US8843199B2 (en)2003-12-122014-09-23Cardiac Pacemakers, Inc.Cardiac response classification using multisite sensing and pacing
US9308375B2 (en)2003-12-122016-04-12Cardiac Pacemakers, Inc.Cardiac response classification using multisite sensing and pacing
US20060129196A1 (en)*2004-12-132006-06-15Yanting DongCapture verification with intrinsic response discrimination
US7761162B2 (en)2004-12-132010-07-20Cardiac Pacemakers, Inc.Capture verification with intrinsic response discrimination
US20090069858A1 (en)*2005-04-282009-03-12Yanting DongCapture Detection for Multi-Chamber Pacing
US8116870B2 (en)2005-04-282012-02-14Cardiac Pacemakers, Inc.Capture detection for multi-chamber pacing
US20070016261A1 (en)*2005-07-122007-01-18Yanting DongMulti channel approach to capture verification
US7529578B2 (en)2005-07-122009-05-05Cardiac Pacemakers, Inc.Multi channel approach to capture verification
US20090240301A1 (en)*2005-07-122009-09-24Yanting DongMulti Channel Approach to Capture Verfication
US7979113B2 (en)2005-07-122011-07-12Cardiac Pacemakers, Inc.Multi channel approach to capture verification

Also Published As

Publication numberPublication date
US5284491A (en)1994-02-08
AU3433193A (en)1993-09-13
WO1993016756A1 (en)1993-09-02

Similar Documents

PublicationPublication DateTitle
USRE37454E1 (en)Cardiac pacemaker with hystersis behavior
US5549649A (en)Programmable pacemaker including an atrial rate filter for deriving a filtered atrial rate used for switching pacing modes
US5085215A (en)Metabolic demand driven rate-responsive pacemaker
EP1105188B1 (en) apparatus for prevention of atrial tachyarrhythmias
EP0596598B1 (en)Cardiac rhythm management device with automatic optimization of performance related pacing parameters
US5441523A (en)Forced atrioventricular synchrony dual chamber pacemaker
EP0796129B1 (en)Cardiac pacemakers using sinus preference method
EP0774274B1 (en)Pacemaker with automatic blanking period function
US6501988B2 (en)Apparatus and method for ventricular rate regularization with biventricular sensing
EP0360668B1 (en)Dual chamber rate responsive pacemaker
EP0621055B1 (en)Rate adaptive pacemaker with adjustment of sensor rate as a function of sensed sinus rate
US4941471A (en)Rate stabilization pacemaker
EP0559847B1 (en)Dual chamber rate responsive pacemaker with automatic mode switching
EP0652029B1 (en)Rate adaptive dual chamber pacing system with automatic adjustment of operating parameters for minimizing sensor-sinus competition
EP1901804B1 (en)Atrial capture management in minimal ventricular pacing system
US5968081A (en)System and method for providing improved fallback response in a dual-chamber cardiac pacemaker
US7103411B1 (en)Methods and apparatus for preventing atrial arrhythmias by overdrive pacing multiple heart tissue sites using an implantable cardiac stimulation device
US8565875B2 (en)Cardiac rhythm management system with maximum tracking rate (MTR) hysteresis
EP0559193A2 (en)Implantable pacemaker providing hysteresis in dual-chamber modes
US5423868A (en)Dual chamber pacemaker which detects, confirms and terminates pacemaker mediated tachycardia
JP4347699B2 (en) Pacemaker with adaptive arrhythmia detection window
EP0148486B1 (en)Improved rate adaptive pacemaker apparatus

Legal Events

DateCodeTitleDescription
FEPPFee payment procedure

Free format text:PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAYFee payment

Year of fee payment:12


[8]ページ先頭

©2009-2025 Movatter.jp